2026 Wmif New Approaches To Developing Ii Therapies Solving The Unmet Need

Summary

Speakers Meredith Fisher PhD, Partner, Mass General Brigham Ventures (Moderator) Niranjana Nagarajan MSc, PhD, Chief ... Summary Rishi Singh MD moderated a wide-ranging ophthalmology discussion with Lance Baldo MD, Jason Comander MD, PhD ... Summary The first generation of cell and gene Speakers Jason Zemansky, US SMid-Cap Biotechnology Analyst, BofA Securities (Moderator) Jason Gerberry, US Large Cap ... Summary Medtech is in a period of extraordinary scientific opportunity, but getting a Speakers Tazeen Ahmad, Large Cap and SMid-Cap Biotech Analyst, BofA Securities (Moderator) Reza Dana MD, Director, ... Speakers Jason Gerberry, US Large Cap Pharma and Specialty Pharma Analyst, BofA Securities (Moderator) Alec Stranahan, US ... Summary Patients are already using artificial intelligence to understand symptoms, interpret test results and prepare for ... Summary Immunology has become very good at suppressing inflammation. The next question is whether Summary What if companies could understand a clinical problem before they started designing the solution? Mark Richardson ... Summary RNA interference has moved from a Nobel Prize-winning discovery to a validated drug platform, and John Harris MD, ...